Is MGM-16 Legal in Nevada? (2026)

Instrument

NV KCPA - age 18, adulteration, labeling (NO cap, NO synthetic ban)

Source

https://www.leg.state.nv.us/nrs/nrs-597.html

Retrieved

2026-07-07

Fingerprint

a19a9e9f0c3f84d0

1. A person shall not knowingly sell or offer to sell any material, compound, mixture or preparation containing a kratom product to a child under the age of 18 years. 2. A person shall not knowingly prepare, distribute, advertise, sell or offer to sell a kratom product that is adulterated with a substance that affects the quality or strength of the kratom product to such a degree as to render the kratom product injurious to a consumer. A person has not violated the provisions of this subsection if he or she can show by a preponderance of evidence that he or she relied in good faith upon the representations of a manufacturer, processor, packer or distributor of the kratom product. 3. A person shall not sell a kratom product that does not have a label that clearly sets forth the ingredients and directions for the safe and effective use of the kratom product. 4. A person who violates any provision of this section is subject to a civil penalty of not more than $1,000 for each violation. 5. As used in this section, "kratom product" means any product or ingredient containing: (a) Any part of the leaf of the Mitragyna Speciosa plant if the plant contains the alkaloid mitragynine or 7-hydroxymitragynine; or (b) A synthetic material that contains the alkaloid mitragynine or 7-hydroxymitragynine, regardless of whether the product or ingredient is labeled or sold for human consumption.

Instrument

Treatment by Board when substance is designated, rescheduled or deleted as controlled substance by federal law

Source

https://www.leg.state.nv.us/nrs/nrs-453.html

Retrieved

2026-10-29

Fingerprint

35761c7f56e58bf8

453.2182
  
Treatment by Board when substance is designated, rescheduled or
deleted as controlled substance by federal law.
  
If
a substance is designated, rescheduled or deleted as a controlled substance
pursuant to federal law, the Board shall similarly treat the substance pursuant
to the provisions of
NRS 453.011
 to
453.552
, inclusive, after the expiration of
60 days from publication in the Federal Register of a final order designating a
substance as a controlled substance or rescheduling or deleting a substance or
from the date of issuance of an order of temporary scheduling under Section 508
of the federal Dangerous Drug Diversion Control Act of 1984, 21 U.S.C. §
811(h), unless within the 60-day period, the Board or an interested party
objects to the treatment of the substance. If no objection is made, the Board
shall adopt, without making the determinations or findings required by
subsections 1 to 4, inclusive, of
NRS
453.146
 or
NRS 453.166
,
453.176
,
453.186
,

453.196
 or
453.206
, a final regulation treating the
substance. If an objection is made, the Board shall make a determination with
respect to the treatment of the substance as provided by subsections 1 to 4,
inclusive, of
NRS 453.146
. Upon receipt
of an objection to the treatment by the Board, the Board shall publish notice
of the receipt of the objection, and action by the Board is stayed until the
Board adopts a regulation as provided by subsection 4 of
NRS 453.146
.

      (Added to NRS by
1991,
1644
; A
2001,
1056
;
2003,
552
)

Instrument

Prohibited acts relating to sale, preparation, distribution or advertisement of kratom products or products containing kratom

Source

https://www.leg.state.nv.us/nrs/nrs-597.html

Retrieved

2026-11-08

Fingerprint

a00a1ecc5ae992bd

1.  A person shall not knowingly sell or
offer to sell any material, compound, mixture or preparation containing a
kratom product to a child under the age of 18 years. 

2.  A person shall not knowingly prepare,
distribute, advertise, sell or offer to sell a kratom product that is
adulterated with a substance that affects the quality or strength of the kratom
product to such a degree as to render the kratom product injurious to a
consumer. A person has not violated the provisions of this subsection if he or
she can show by a preponderance of evidence that he or she relied in good faith
upon the representations of a manufacturer, processor, packer or distributor of
the kratom product. 

3.  A person shall not sell a kratom
product that does not have a label that clearly sets forth the ingredients and
directions for the safe and effective use of the kratom product.

4.  A person who violates any provision of
this section is subject to a civil penalty of not more than $1,000 for each violation.

5.  As used in this section, kratom
product means any product or ingredient containing:

(a) Any part of the leaf of the 
Mitragyna
Speciosa
plant if the plant contains the alkaloid mitragynine or
7-hydroxymitragynine; or

(b) A synthetic material that contains the
alkaloid mitragynine or 7-hydroxymitragynine,

regardless
of whether the product or ingredient is labeled or sold for human consumption.